Newborn pain study pulled before it began
NCT ID NCT01667120
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 26 times
Summary
This study planned to test whether a pain medicine called ketorolac is safe and effective for newborns up to 3 months old after abdominal surgery. The goal was to see if it could reduce the need for stronger narcotic painkillers. However, the study was withdrawn before any babies were enrolled, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTOPERATIVE PAIN CONTROL IN SURGICAL NEONATES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nationwide Children's Hospital
Columbus, Ohio, 43205, United States
Conditions
Explore the condition pages connected to this study.